As of 2025-05-17, the Intrinsic Value of Mevis Medical Solutions AG (M3V.DE) is 46.55 EUR. This M3V.DE valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 25.80 EUR, the upside of Mevis Medical Solutions AG is 80.40%.
The range of the Intrinsic Value is 37.67 - 62.08 EUR
Based on its market price of 25.80 EUR and our intrinsic valuation, Mevis Medical Solutions AG (M3V.DE) is undervalued by 80.40%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 37.67 - 62.08 | 46.55 | 80.4% |
| DCF (Growth 10y) | 40.98 - 65.80 | 50.05 | 94.0% |
| DCF (EBITDA 5y) | 22.07 - 27.26 | 24.93 | -3.4% |
| DCF (EBITDA 10y) | 28.20 - 35.14 | 31.75 | 23.1% |
| Fair Value | 21.40 - 21.40 | 21.40 | -17.06% |
| P/E | 72.73 - 91.85 | 88.49 | 243.0% |
| EV/EBITDA | 17.17 - 48.55 | 33.22 | 28.8% |
| EPV | 49.87 - 67.88 | 58.88 | 128.2% |
| DDM - Stable | 38.00 - 88.51 | 63.26 | 145.2% |
| DDM - Multi | 18.97 - 35.61 | 24.87 | -3.6% |
| Market Cap (mil) | 46.96 |
| Beta | 0.09 |
| Outstanding shares (mil) | 1.82 |
| Enterprise Value (mil) | 46.96 |
| Market risk premium | 4.74% |
| Cost of Equity | 9.40% |
| Cost of Debt | 4.25% |
| WACC | 6.79% |